← Evidence map

TrialTargeted oncology2025

Elranatamab Fixed Dosing: A Safe, Effective, and Convenient Dosing Approach.

Mohamed Elmeliegy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40830740